Recent experimental evidence supports the fundamental role of AD-related peptides early in the pathology: in particular, the most widely studied amyloid beta (Aβ) and the less investigated amyloid precursor protein (APP) C-terminal peptide (AICD). The gene discussed is APP; the disease is Alzheimer disease.